Evidence map›Paper›PMID 42598399›Full record

ArticleACS omega2026

Advancing Sustainable Solid-Phase Peptide Synthesis: The Role of 1‑(3-(Dimethylamino)propyl)-3-ethylcarbodiimide Methotosylate (EDC·MeTos) in Green Solvents.

Maria Carmina Scala, Martina Landi, Giovanni Vivenzio, Pietro Campiglia, Marina Sala

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maria Carmina ScalaDepartment of Pharmacy, University of Salerno, via Giovanni Paolo II, Fisciano, Salerno 84084, Italy.
Martina LandiDepartment of Pharmacy, University of Salerno, via Giovanni Paolo II, Fisciano, Salerno 84084, Italy.
Giovanni VivenzioDepartment of Pharmacy, University of Salerno, via Giovanni Paolo II, Fisciano, Salerno 84084, Italy.
Pietro CampigliaDepartment of Pharmacy, University of Salerno, via Giovanni Paolo II, Fisciano, Salerno 84084, Italy.ORCID https://orcid.org/0000-0002-1069-2181
Marina SalaDepartment of Pharmacy, University of Salerno, via Giovanni Paolo II, Fisciano, Salerno 84084, Italy.ORCID https://orcid.org/0000-0003-2739-7215

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbodiimides are essential reagents in peptide synthesis due to their ability to activate carboxylic acids toward amide bond formation. In this study, we investigated the coupling efficiency and racemization propensity of 1-(3-(Dimethylamino)-propyl)-3-ethylcarbodiimide methotosylate (EDC·MeTos), both alone and in combination with ethyl 2-cyano-2-(hydroxyimino)-acetate (OxymaPure), under green solvent conditions as alternatives to the conventional use of N,N-dimethylformamide (DMF). Using Fmoc-based solid-phase peptide synthesis (SPPS), we synthesized several model peptides to assess the coupling efficiency, side-product formation, and epimerization levels across different reaction media. Our results demonstrate that the binary green solvent system EtOAc/DMSO (ethyl acetate/dimethyl sulfoxide, 9:1) supports highly efficient peptide couplings when used with quaternary carbodiimides (QCD), producing peptides of comparable purity to those synthesized in DMF. Remarkably, the use of QCD alone in this green medium led to lower racemization levels than in DMF, highlighting a dual advantage in terms of both environmental impact and stereochemical integrity. The additive OxymaPure was beneficial for sterically hindered sequences such as Aib-ACP (α-aminoisobutyric acid-ACP), but not essential for less demanding peptides. Overall, the findings support the viability of green solvent systems in high-fidelity peptide synthesis, enabling more sustainable manufacturing practices.

Identifiers

PMID42598399
PMCPMC13470756

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.